Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 601

1.

Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.

Scott LJ.

BioDrugs. 2010 Dec 1;24(6):387-406. doi: 10.2165/11206000-000000000-00000. Review.

PMID:
21043546
[PubMed - indexed for MEDLINE]
2.
3.

Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.

McCormack PL.

Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000. Review.

PMID:
22931522
[PubMed - indexed for MEDLINE]
4.
5.

Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV; Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.

PMID:
16557217
[PubMed - indexed for MEDLINE]
Free Article
6.
7.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
[PubMed - indexed for MEDLINE]
8.

Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.

Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee.

MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.

PMID:
17167397
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
[PubMed - indexed for MEDLINE]
11.

A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial.

Scheifele DW, Halperin SA, Ochnio JJ, Ferguson AC, Skowronski DM.

Pediatr Infect Dis J. 2005 Dec;24(12):1059-66. Erratum in: Pediatr Infect Dis J. 2006 Mar;25(3):229.

PMID:
16371866
[PubMed - indexed for MEDLINE]
12.

Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults.

Mertsola J, Van Der Meeren O, He Q, Linko-Parvinen A, Ramakrishnan G, Mannermaa L, Soila M, Pulkkinen M, Jacquet JM.

Clin Infect Dis. 2010 Sep 15;51(6):656-62. doi: 10.1086/655825.

PMID:
20704493
[PubMed - indexed for MEDLINE]
Free Article
13.

Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age.

Blatter M, Friedland LR, Weston WM, Li P, Howe B.

Vaccine. 2009 Jan 29;27(5):765-72. doi: 10.1016/j.vaccine.2008.11.028. Epub 2008 Nov 27.

PMID:
19041352
[PubMed - indexed for MEDLINE]
14.

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.

Pichichero ME, DeTora LM, Johnson DR.

Expert Rev Vaccines. 2006 Apr;5(2):175-87. Review.

PMID:
16608418
[PubMed - indexed for MEDLINE]
15.
16.

Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.

Pichichero ME, Blatter MM, Kennedy WA, Hedrick J, Descamps D, Friedland LR.

Pediatrics. 2006 Apr;117(4):1084-93.

PMID:
16585302
[PubMed - indexed for MEDLINE]
Free Article
17.

Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.

Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.

Vaccine. 2005 May 25;23(28):3657-67.

PMID:
15882526
[PubMed - indexed for MEDLINE]
18.

Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.

Black S, Friedland LR, Ensor K, Weston WM, Howe B, Klein NP.

Pediatr Infect Dis J. 2008 Apr;27(4):341-6. doi: 10.1097/INF.0b013e3181616180.

PMID:
18316985
[PubMed - indexed for MEDLINE]
19.

Acellular pertussis vaccine for adolescents.

de Carvalho AP, Pereira EM.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S15-24. Epub 2006 Jun 16. Review.

PMID:
16786100
[PubMed - indexed for MEDLINE]
Free Article
20.

An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.

Lee CY, Thipphawong J, Huang LM, Lee PI, Chiu HH, Lin W, Debois H, Harrison D, Xie F, Barreto L.

Pediatrics. 1999 Jan;103(1):25-30.

PMID:
9917435
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk